Interestingly, we observed that the nucleoside analogue 8AA, which activates p53–independent cell death pathways [41], was more cytotoxic to G/G SNP309 cancer cells than etoposide or actinomycin D suggesting it is a viable option for cancers with dysfunctional p53. This evidence concerns the gene TP53 and cancer.